Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 33,174	$ 65,562
Marketable securities	7,130	11,427
Prepaid expenses and other assets	564	442
Prepaid acquisition cost	301
Short-term investments at fair value	13	2,273
Notes receivable at fair value	7,474	6,984
Investment deposit		4,201
Investment in FieldPoint Securities	2,000
Total current assets	50,656	90,889
Convertible note receivable at fair value		2,147
Notes receivable at fair value	1,100
Investments	23,103	9,465
Right-of-use assets	919
Security deposit	458	155
Total assets	76,236	102,656
Current liabilities
Accounts payable and accrued expenses	447	381
Accrued salaries and benefits	1,260	680
Lease liability - current	82
Total current liabilities	1,789	1,061
Lease liability	680
Total liabilities	2,469	1,061
Stockholders’ equity
Preferred stock value
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,485,096 and 5,275,329 shares issued at December 31, 2022 and 2021, respectively; 5,017,079 and 5,275,329 shares outstanding at December 31, 2022 and 2021, respectively
Additional paid-in capital	262,970	265,633
Treasury stock, at cost, 468,017 and 0 shares at December 31, 2022 and 2021, respectively	(3,322)	(264)
Accumulated deficit	(185,881)	(163,774)
Total stockholders’ equity	73,767	101,595
Total liabilities and stockholders’ equity	76,236	102,656
Series D Preferred Stock
Stockholders’ equity
Preferred stock value
Series D-1 Preferred Stock
Stockholders’ equity
Preferred stock value